Literature DB >> 20853069

Blood-born tissue factor in cardiovascular disease: where are we now?

Vincenzo Toschi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20853069     DOI： 10.1007/s11739-010-0460-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  15 in total

1.  Pathology of the vulnerable plaque.

Authors:  Renu Virmani; Allen P Burke; Andrew Farb; Frank D Kolodgie
Journal:  J Am Coll Cardiol       Date:  2006-04-18       Impact factor: 24.094

2.  Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.

Authors:  Jun-o Deguchi; Masanori Aikawa; Ching-Hsuan Tung; Elena Aikawa; Dong-Eog Kim; Vasilis Ntziachristos; Ralph Weissleder; Peter Libby
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

Review 3.  Tissue factor and cardiovascular disease: quo vadis?

Authors:  Alexander Breitenstein; Felix C Tanner; Thomas F Lüscher
Journal:  Circ J       Date:  2009-12-08       Impact factor: 2.993

4.  Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.

Authors:  J J Badimon; M Lettino; V Toschi; V Fuster; M Berrozpe; J H Chesebro; L Badimon
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

Review 5.  Atherothrombosis and high-risk plaque: part I: evolving concepts.

Authors:  Valentin Fuster; Pedro R Moreno; Zahi A Fayad; Roberto Corti; Juan J Badimon
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

Review 6.  Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?

Authors:  Giovanni Cimmino; Paolo Golino; Juan Jose Badimon
Journal:  Intern Emerg Med       Date:  2010-07-07       Impact factor: 3.397

7.  Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.

Authors:  P A Merlini; D Ardissino; K A Bauer; L Oltrona; A Pezzano; B Bottasso; R D Rosenberg; P M Mannucci
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-07       Impact factor: 8.311

8.  Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.

Authors:  Marta Brambilla; Marina Camera; Deborah Colnago; Giancarlo Marenzi; Monica De Metrio; Peter L Giesen; Alessandra Balduini; Fabrizio Veglia; Karl Gertow; Paolo Biglioli; Elena Tremoli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

Review 9.  The molecular mechanisms of the thrombotic complications of atherosclerosis.

Authors:  P Libby
Journal:  J Intern Med       Date:  2008-05       Impact factor: 8.989

10.  Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.

Authors:  Vladimir Y Bogdanov; Viji Balasubramanian; James Hathcock; Oana Vele; Mark Lieb; Yale Nemerson
Journal:  Nat Med       Date:  2003-03-24       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.